We are Epilepsy Society. The UK's leading charity for epilepsy research and support.
Due to current circumstances in relation to the coronavirus some of our services have been reduced with our staff working from home. Despite this our top priority at Epilepsy Society is to support people living with epilepsy. You may notice a slight change in our communications. For the time being, we will focus our efforts on making sure you have all the information you need from us to help you as best we can in the current climate.
The Chalfont Centre and our Gowers unit lead the way in the most advanced techniques for the diagnosis and treatment of epilepsy.
We are the leading charity care provider, where people love to work and live. Our wide range of care is tailored to the needs of each individual, and our professional staff are committed to maximising the life potential of everyone within our care homes.
Our campaigns team lobby government and decision-makers on the issues that matter to people with epilepsy. From safer medicines for pregnant women to the dangers of online harm, and from medicines supply to public transport access, we raise awareness of the daily challenges facing people with epilepsy – putting your needs at the heart of what we do.
Two new initiatives have been launched to help ensure that all women with epilepsy, of child-bearing age, are aware of the risks associated with the medication valproate, during pregnancy.
MPs, scientists and clinicians today backed Epilepsy Society’s call for the government to stop babies from being born with preventable disabilities, by investing more money into urgent research.
The Epilepsy Society has welcomed the publication of a new Bill which aims to promote online safety, but we believe more needs to be done to protect people with epilepsy from internet trolling.
We know from calls to our Helpline, and through conversation on our social media platforms, that some people are sharing concerns about having their second dose of the Covid-19 vaccine.
The Epilepsy Society has welcomed the Health Secretary's promise to invest in cutting-edge research which could lead to safer medicines and better treatments for a variety of conditions, including epilepsy.
Footballers are putting up a united front alongside people with epilepsy as they ask Prince William, president of the Football Association, for his support in tackling internet trolls.
The ultimate goals of our current research are to spearhead personalised treatment and to incorporate genomic diagnosis into the NHS for people with epilepsy.
Therapeutic drug monitoring (TDM) is an area of clinical chemistry that specialises in measuring medication levels (concentrations) in patients, usually through blood samples but also through saliva samples.
Read how we are working to understand the genetic architecture of each individual person's epilepsy through our world leading genomics research programme.
You can call our helpline on 01494 601 400.
Our Helpline is open five days a week, Monday to Friday 9am to 4pm, (Wednesday 9am to 7.30pm).
You can also reach us by email
Please support us.
In these challenging times, charities like Epilepsy Society rely on donations to ensure vital services for our beneficiaries can continue. If you can spare a donation or pledge a monthly gift, you will be helping to ensure we continue to support everyone affected by epilepsy. Thank you.